Cell Reports Medicine (@cellrepmed) 's Twitter Profile
Cell Reports Medicine

@cellrepmed

Broad-scope #OA journal from @CellPressNews publishing cutting-edge science across the spectrum of #Translational and #ClinicalResearch | Editor: @DrSaraHam

ID: 1181623999152963584

linkhttps://www.cell.com/cell-reports-medicine calendar_today08-10-2019 17:40:00

1,1K Tweet

19,19K Takipçi

387 Takip Edilen

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2 dlvr.it/TCRtG3

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: CTC-derived pancreatic cancer models serve as research tools and are suitable for precision medicine approaches dlvr.it/TCTcMk

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Machine learning-based analysis identifies and validates serum exosomal proteomic signatures for the diagnosis of colorectal cancer dlvr.it/TCVDTh

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data dlvr.it/TCWhtF

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level dlvr.it/TCZ28X

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance dlvr.it/TCjKMh

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma dlvr.it/TCk8FY

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: HSD3B1 genotype and outcomes in metastatic hormone-sensitive prostate cancer with androgen deprivation therapy and enzalutamide: ARCHES dlvr.it/TCmph5

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial dlvr.it/TCpjyy

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2 dlvr.it/TD1Jw1

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Next-generation lung cancer pathology: Development and validation of diagnostic and prognostic algorithms dlvr.it/TD3m6n

Cell Reports Medicine (@cellrepmed) 's Twitter Profile Photo

Online now: Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization dlvr.it/TD4NgR